InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by MOORE JOHN R, Conseiller Juridique Général. Insider active across 1 company, notably Edgewise Therapeutics, Inc.. In total, 9 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €77k. Activity tracked since 28 December 2021. The latest transaction was filed on 16 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
14,722 shares@ US$1.930.0010% mcap17.3% of flowCommon StockSEC:0001562180-22-005251:0
4,093 shares@ US$0.710.0001% mcap1.8% of flowCommon StockSEC:0001562180-22-005126:0
12,566 shares@ US$0.710.0003% mcap5.3% of flowCommon StockSEC:0001562180-22-005053:0
15,230 shares@ US$1.930.0010% mcap17.6% of flowCommon StockSEC:0001562180-22-004887:0
10,800 shares@ US$7.42090.0029% mcap49.3% of flowCommon StockSEC:0001562180-22-004201:0
5,400 shares@ US$0.710.0001% mcap2.2% of flowCommon StockSEC:0001562180-22-000645:0
5,400 shares@ US$0.710.0001% mcap50.0% of flowCommon StockSEC:0001562180-22-000645
5,400 shares@ US$0.710.0001% mcap50.0% of flowCommon StockSEC:0001562180-21-007920
5,400 shares@ US$0.710.0001% mcap2.2% of flowCommon StockSEC:0001562180-21-007920:0
9 of 9 declarations
About MOORE JOHN R
John R. Moore serves as General Counsel at Edgewise Therapeutics, Inc. In this role, he oversees the company's legal affairs and ensures compliance with regulations. Moore plays a crucial role in managing legal risks and protecting the company's interests. His expertise in business law is vital for the success of Edgewise Therapeutics.
